Laurence Huang, MD

Phone: 415-476-4082 ext. 406
UCSF Box: 0874
Email: [email protected]
UCSF Profile

Project Sponsor Location(s) Topics Start End
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study NIH National Heart, Lung, and Blood Institute Uganda HIV/AIDS, Chronic Respiratory Disease
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases NIH National Heart, Lung, and Blood Institute Uganda HIV/AIDS, Tuberculosis, Noncommunicable and/or Chronic Disease
Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes University of Pittsburgh United States Chronic Respiratory Disease
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV U of Colorado Denver/Anschutz Medical C United States HIV/AIDS, Chronic Respiratory Disease
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis University of Colorado Denver, Anschutz Medical Campus Uganda HIV/AIDS, Tuberculosis
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study NIH National Heart, Lung, and Blood Institute United States HIV/AIDS
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV University of Pittsburgh United States HIV/AIDS, Chronic Respiratory Disease
Transcriptional alterations in bronchoalveolar lavage fluid during treatment of human tuberculosis. University of Colorado Denver, Anschutz Medical Campus United States Tuberculosis
Specimens Related to the MU-UCSF Research Collaboration Makerere University Uganda HIV/AIDS
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial) University of Pittsburgh United States HIV/AIDS
International HIV-Associated Opportunistic Pneumonias (IHOP) Study NIH National Heart, Lung, and Blood Institute Uganda; United Kingdom HIV/AIDS
Patient-Oriented Research and Mentoring in Pneumocystis NIH National Heart, Lung, and Blood Institute Uganda
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll) University of Washington (UW) United States HIV/AIDS
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l)) Yale University United States HIV/AIDS
FIND Xpert MTB assay collaboration at Mulago Hospital Foundation for Innovative New Diagnostics Uganda Tuberculosis
International HIV-Associated Opportunistic Pneumonias (IHOP) Study NIH National Heart, Lung, and Blood Institute Uganda; United Kingdom; United States HIV/AIDS
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease University of Washington (UW) United States HIV/AIDS, Chronic Respiratory Disease
PCP OPW Specimens/Uganda Project Support NIH Warren Grant Magnuson Clinical Center Uganda Infectious Disease, HIV/AIDS, Opportunistic Infection
UCSF-FIND Uganda Project Foundation for Innovative New Diagnostics Uganda Tuberculosis, Drug and Diagnostics Development
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Immtech Pharmaceuticals, Inc. United States HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Molecular Epidemiology of Human P. Carinii Pneumonia NIH National Heart, Lung, and Blood Institute United States
Evaluate Serum-Based Assay for Pneumocystis Pneumonia Diagnosis U.S. Department of Veterans Affairs United States Chronic Respiratory Disease
PCP OPW Specimens NIH Warren Grant Magnuson Clinical Center Uganda Opportunistic Infection